Prevalence of atrial fibrillation, oral anticoagulation prescription and associated factors in Brazilian older adults

Geriatrics, Gerontology and Aging

Endereço:
Avenida Nossa Senhora de Copacabana,500 - 609 - Copacabana
Rio de Janeiro / RJ
22020001
Site: http://ggaging.com
Telefone: (21) 2285-8115
ISSN: 2447-2123
Editor Chefe: Patrick Alexander Wachholz
Início Publicação: 10/10/2007
Periodicidade: Anual
Área de Estudo: Ciências da Saúde, Área de Estudo: Educação física, Área de Estudo: Enfermagem, Área de Estudo: Farmácia, Área de Estudo: Fisioterapia e terapia ocupacional, Área de Estudo: Fonoaudiologia, Área de Estudo: Medicina, Área de Estudo: Nutrição, Área de Estudo: Odontologia, Área de Estudo: Saúde coletiva, Área de Estudo: Serviço social, Área de Estudo: Multidisciplinar

Prevalence of atrial fibrillation, oral anticoagulation prescription and associated factors in Brazilian older adults

Ano: 2020 | Volume: 14 | Número: 4
Autores: Vitor Pelegrim de Oliveiraa; Renato Gorga Bandeira de Mellob; Andry Fiterman Costac; Roberta Rigo Dalla Corteb; Francine da Rocha Floresb; Nicóli Bertuol Xavierb; Nathália Marzotto Nunesb; Emilio Hideyuki Moriguchib
Autor Correspondente: Vitor Pelegrim de Oliveira | [email protected]

Palavras-chave: atrial fibrillation; anticoagulants; prevalence; geriatrics; cerebral infarction.

Resumos Cadastrados

Resumo Inglês:

INTRODUCTION: Atrial fibrillation increases five times the risk of stroke. Anticoagulation reduces the incidence of cerebrovascular events. However, many patients do not receive thromboprophylaxis.
OBJECTIVES: To estimate the prevalence of atrial fibrillation in the older patients at a Brazilian university hospital and the proportion of anticoagulation prescription. Secondary objectives were to identify the therapeutic options, the main reasons for non-prescription and the factors associated with ineffectiveness or lack of treatment.
METHODS: This was a cross-sectional study with a consecutive sample of 1,630 outpatients selected at Hospital de Clínicas de Porto Alegre between April and June of 2017. Atrial fibrillation was identified in 220 (13.50%) individuals. t Medical records from 145 patients were accessed, followed by a telephone interview. The association between variables and “ outcomes was checked using the Mann-Whitney’s U Test and a chi-squared test.
RESULTS: The prevalence of atrial fibrillation was 13.50%. Anticoagulation therapy was prescribed in 77.93% of cases. In 76.11% of patients, warfarin was the chosen drug. < There was a tendency towards no prescription in patients with previous bleeding (RR = 2.32; 95%CI 0.95 - 5.64; p = 0.06) and falls (RR = 2.02; 95%CI 0.82 - 5.03; p = 0.08). We found an association between reduced functional capacity (Barthel’s Activities of Daily Living Score < 80) and higher rate of anticoagulation in therapeutic target (RR = 0.22; 95%CI 0.06 - 0.87; p = 0.04).
CONCLUSION: The prevalence of atrial fibrillation in this population was 13.50% and in 77.93% of cases anticoagulant were prescribed. Functional impairment was associated with a higher rate of anticoagulation in therapeutic target.